Novel heterotypic cell cultures for liver toxicology studies

用于肝毒理学研究的新型异型细胞培养物

基本信息

  • 批准号:
    8323544
  • 负责人:
  • 金额:
    $ 18.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of our proposal is to investigate paracrine fibrogenic signaling between parenchymal and non parenchymal liver cells during alcohol injury. Whereas the nonparenchymalcompartment (stellate cells) remains the major player in the development of liver, the role of the parenchymal cells (hepatocytes) in this process is drawing increasing attention. Improved understanding of the roles played by parenchymal and nonparenchymalliver cells during alcohol insult will translate into better, more effective and targeted therapeutics. However, the complex signaling exchange between different liver cell types is difficult to delineate with in vivo models or standard in vitro cell culture approaches. In this proposal, we will utilize a novel liver cell culture approach to investigate !he hypothesis that hepatic production of transforming growth factor (TGF)-¿ plays an important role in initiating the fibrogneic program of stellate cells. This hypothesis will be explored using a novel cell culture system where cell adhesive and/or signaling molecules are imprinted into a culture substrate so as to position discrete groups of hepatocytes and stellate cells in defined locations and in close proximity to each other (see Figure 1 (A,B)). As shown in Figure 1 C, this novel cell culture dish will be used to selectively stimulate hepatocytes within the co-cultures with anti-fibrotic growth factors (GFs) (e.g. HGF and BMP7) during alcohol injury in order to investigate how GF signals delivered to hepatocytes impact activation of neighboring stellate cells. The novelty of the proposed platform lies in our ability to define interactions of two liver cell types cultured in the same dish so as to modulate the phenotype of one cell type and to study the response of the other cell type. This approach is particularly well-suited for improving our understanding of the complex heterotypic signaling underlying liver fibrosis. The novel cell culture system described here is envisioned as an enabling technology for liver toxicology studies and for high-throughput screening of liver-protective molecules.
描述(由申请人提供):我们建议的目标是研究酒精损伤过程中实质和非实质肝细胞之间的旁分泌纤维形成信号。虽然非实质室(星状细胞)仍然是肝脏发育的主要参与者,但实质细胞(肝细胞)在这一过程中的作用正受到越来越多的关注。更好地理解实质细胞和非实质细胞在酒精侮辱中所起的作用将转化为更好、更有效和更有针对性的治疗方法。然而,不同类型的肝细胞之间复杂的信号交换很难用体内模型或标准的体外细胞培养方法来描述。在这项建议中,我们将利用一种新的肝细胞培养方法来研究这一假说,即肝脏产生转化生长因子(TGF)-β在启动星状细胞的纤维化程序中起着重要作用。这一假设将使用一种新型的细胞培养系统来探索,在该系统中,细胞黏附分子和/或信号分子被印记在培养底物中,以便将离散的肝细胞组和星状细胞组定位在指定的位置和彼此紧密接近的位置(见图1(A,B))。如图1C所示,这种新型细胞培养皿将用于在酒精损伤期间选择性地刺激与抗纤维化生长因子(GFS)(如HGF和BMP7)共培养的肝细胞,以研究传递给肝细胞的GF信号如何影响邻近星状细胞的激活。该平台的新奇之处在于,我们能够定义在同一培养皿中培养的两种肝细胞类型的相互作用,从而调节一种细胞类型的表型,并研究另一种细胞类型的反应。这种方法特别适合于提高我们对肝纤维化背后复杂的异型信号的理解。这里描述的新型细胞培养系统被设想为一种能够用于肝脏毒理学研究和高通量筛选肝脏保护分子的技术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Revzin其他文献

Alexander Revzin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Revzin', 18)}}的其他基金

Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
用于肝脏疾病细胞外囊泡高灵敏度和样品节省分析的质谱法
  • 批准号:
    10736006
  • 财政年份:
    2023
  • 资助金额:
    $ 18.29万
  • 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
  • 批准号:
    9882916
  • 财政年份:
    2020
  • 资助金额:
    $ 18.29万
  • 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
  • 批准号:
    10155447
  • 财政年份:
    2020
  • 资助金额:
    $ 18.29万
  • 项目类别:
Context rich mass spectrometry of molecular localization and cellular interactions
分子定位和细胞相互作用的上下文丰富质谱分析
  • 批准号:
    9751908
  • 财政年份:
    2017
  • 资助金额:
    $ 18.29万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9215666
  • 财政年份:
    2016
  • 资助金额:
    $ 18.29万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9889953
  • 财政年份:
    2016
  • 资助金额:
    $ 18.29万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9412328
  • 财政年份:
    2016
  • 资助金额:
    $ 18.29万
  • 项目类别:
Novel heterotypic cell cultures for liver toxicology studies
用于肝毒理学研究的新型异型细胞培养物
  • 批准号:
    8054693
  • 财政年份:
    2011
  • 资助金额:
    $ 18.29万
  • 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
  • 批准号:
    8448619
  • 财政年份:
    2010
  • 资助金额:
    $ 18.29万
  • 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
  • 批准号:
    8066334
  • 财政年份:
    2010
  • 资助金额:
    $ 18.29万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 18.29万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 18.29万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了